Nuvectis Pharma | Investor Presentation Deck | 25 slides · page 12 of 25
The slide uses a patient selection strategy based on ARID1a mutation status.
Pitch deck · market_sizing · size_opportunity · dense density
Slide locked Sign in to view
Slide schematic 4/4
paragraph 1/1 source-note 1/1 table 1/1 title 1/1
Components 4
paragraph source-note data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.